Jay M. Short Ph.D., Chief Executive Officer at BioAtla, Inc. (BCAB), sold 87,629 shares at $21.74 ($2.1M) on 2021-12-02, disclosed to the SEC on 2021-12-07.
Open-market sale of $2.1M BCAB by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $24.00 | 7,519 | $180K | 8.8% |
| 2 | $24.68 | 8,126 | $201K | 9.8% |
| 3 | $24.68 | 8,126 | $201K | 9.8% |
| 4 | $25.38 | 2,845 | $72K | 3.5% |
| 5 | $25.38 | 2,845 | $72K | 3.5% |
| 6 | $22.19 | 7,829 |
| $174K |
| 8.5% |
| 7 | $22.19 | 7,829 | $174K | 8.5% |
| 8 | $23.27 | 13,539 | $315K | 15.3% |
| 9 | $23.27 | 13,539 | $315K | 15.3% |
| 10 | $24.22 | 2,953 | $72K | 3.5% |
| 11 | $24.22 | 2,953 | $72K | 3.5% |
| 12 | $21.74 | 4,715 | $103K | 5.0% |
| 13 | $21.74 | 4,715 | $103K | 5.0% |
| 14 | $22.47 | 96 | $2K | 0.1% |
| Total | $23.44 avg | 87,629 | $2.1M | 100% |
| Filing → |
| BCAB | BUY | 2022-08-15 | $207K | — | Filing → |
| BCAB | BUY | 2022-06-23 | $397K | — | Filing → |
| BCAB | SELL | 2021-12-06 | $737K | — | Filing → |